Inciardi, R. M., Mentz, R. J., Claggett, B., Ward, J. H., Hernandez, A. F., Morrow, D. A., … Vaduganathan, M. (2024). Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF. In EUROPEAN JOURNAL OF HEART FAILURE (Vol. 26, pp. 67–67).

Inciardi, Riccardo Maria, R. J. Mentz, B. Claggett, J. H. Ward, A. F. Hernandez, D. A. Morrow, R. C. Starling, et al. “Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF.” In EUROPEAN JOURNAL OF HEART FAILURE, 26:67–67, 2024.

Inciardi RM, Mentz RJ, Claggett B, Ward JH, Hernandez AF, Morrow DA, et al. Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF. In: EUROPEAN JOURNAL OF HEART FAILURE. 2024. p. 67–67.

Inciardi, Riccardo Maria, et al. “Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF.” EUROPEAN JOURNAL OF HEART FAILURE, vol. 26, 2024, pp. 67–67.

Inciardi RM, Mentz RJ, Claggett B, Ward JH, Hernandez AF, Morrow DA, Starling RC, Velazquez EJ, Desay AS, Zieroth S, Lefkowitz M, Mcmurray JJV, Braunwald E, Solomon SD, Vaduganathan M. Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF. EUROPEAN JOURNAL OF HEART FAILURE. 2024. p. 67–67.